Key prognostic risk factors linked to poor functional outcomes in cerebral venous sinus thrombosis: a systematic review and meta-analysis

被引:0
作者
Lin, Lili [1 ,2 ]
Liu, Senfeng [2 ]
Wang, Wei [3 ]
He, Xiao-kuo [4 ]
Romli, Muhammad Hibatullah [1 ]
Durai, Ruthpackiavathy Rajen [1 ]
机构
[1] Univ Putra Malaysia, Fac Med & Hlth Sci, Serdang 43400, Selangor, Malaysia
[2] Xiamen Huaxia Univ, Fac Environm & Publ Hlth, Xiamen 361000, Peoples R China
[3] Wenzhou Med Univ, Dept Neurosurg, Affiliated Hosp 1, Wenzhou 325000, Peoples R China
[4] Fifth Xiamen Hosp, Dept Neurol, Xiamen 361000, Peoples R China
关键词
Cerebral venous sinus thrombosis; Stroke; Prognosis; Functional outcome; CLINICAL-FEATURES; PREDICTION SCORE; SEIZURES; LYMPHOCYTE; INSIGHTS; DISEASE; STROKE; DEATH; INDEX; RATIO;
D O I
10.1186/s12883-025-04059-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Cerebral venous sinus thrombosis is a rare stroke with several clinical manifestations. Several studies have identified prognostic risk factors associated with poor functional outcomes and established predictive models. This systematic review and meta-analysis assessed the overall effect size of all prognostic risk factors. Methods A systematic review was conducted to explore all prognostic risk factors in studies published from the initial to June 2024 among 5 Databases included PubMed / Medline, Scopus, EBSCOhost, Web of Science, and Cochran Library. The quality of the methodology was analyzed using the Newcastle-Ottawa Scale. Data analysis was performed using the Statistical Package for Social Sciences (SPSS) version 29. Results Sixty-four studies involving 18,958 participants with a mean age of 38.46 years and females 63.03% were included in the quantitative meta-analysis. Functional outcomes were primarily measured using the Modified Rankin Scale (mRS), with scores >= 2 or >= 3 indicating poor outcomes in 35.00% and 60.00% of studies, respectively. For general information, age (InOR = 0.98, 95% CI 0.53-1.43), intracranial hemorrhage (OR = 3.79, 95% CI 2.77-5.20), and ischemic infarction (OR = 3.18, 95% CI 2.40-4.23) were associated with poor functional outcomes. For general and neurological symptoms, headache (OR = 0.22, 95% CI 0.17-0.29), seizure (OR = 2.74, 95% CI 1.76-4.27), focal deficit (OR = 4.72, 95% CI 3.86-5.78), coma (OR = 11.60, 95% CI 6.12-21.98), and consciousness alteration (OR = 7.07, 95% CI 4.15-12.04) were outstanding factors. The blood biomarkers of NLR (log OR = 1.72, 95% CI 0.96-2.47), lymphocytes (Cohen's d = -0.63, 95 CI -0.78--0.47), and D-dimer (lnOR = 1.34, 95% CI 0.87-1.80) were the three most frequently reported factors. Parenchymal lesion (OR = 4.71, 95% CI 1.12-19.84) and deep cerebral venous thrombosis (OR = 6.30, 95% CI 2.92-13.63) in radiological images were two frequently reported factors. CVST patients with cancer (OR = 3.87, 95% CI 2.95-5.07) or high blood glucose levels (OR = 3.52, 95% CI 1.61-7.68) were associated with poor functional outcomes. In the meta-regression analysis, ischemic infarction (P = 0.032), consciousness alteration (P < 0.001), and NLR (P = 0.015) were associated with mRS prediction. Conclusions Pooled effect sizes revealed that ischemic infarction, headache, neurological focal deficit, lymphopenia, and cancer were significantly associated with poor functional outcomes, with low to moderate heterogeneity. Consciousness alterations/deterioration and deep cerebral venous thrombosis were also significant prognostic factors, albeit with substantial heterogeneity. The meta-regression analysis showed that the effect sizes of consciousness alterations/deterioration and NLR increased with worsening mRS scores. Other notable risk factors included age, intracranial hemorrhage, seizures, coma, D-dimer, parenchymal lesions, and hyperglycemia. This systematic review provides a comprehensive overview of the prognostic risk factors for poor functional outcomes in patients undergoing CVST, which can guide clinical decision-making and future research.
引用
收藏
页数:19
相关论文
共 100 条
[1]   Neurological Predictors of Functional Outcome in Cortical Venous Sinus Thrombosis [J].
Aarju, Gagneja ;
Singh, Paul Birinder ;
Vipin, Kumar ;
Alisha, Saxena ;
Gunchan, Paul .
JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2022, 13 (02) :290-294
[2]   Sex Differences and Clinical Outcomes of Patients with Coronavirus Disease 2019 Infection and Cerebral Venous Sinus Thrombosis: A Systematic Review [J].
Algarni, Saleh A. ;
Alghasab, Naif S. ;
Alharbi, Mohammed S. ;
Albarrak, Anas ;
Alanezi, Ahmad A. ;
Al Shehri, Hamdan M. .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
[3]   Cerebrovascular disease as the initial clinical presentation of haematological disorders [J].
Arboix, A ;
Besses, C .
EUROPEAN NEUROLOGY, 1997, 37 (04) :207-211
[4]   Ischemic stroke of unusual cause:: clinical features, etiology and outcome [J].
Arboix, A ;
Bechich, S ;
Oliveres, M ;
García-Eroles, L ;
Massons, J ;
Targa, C .
EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (02) :133-139
[5]  
Bajko Z, 2021, J Clin Med, V10
[6]   Delayed Diagnosis in Cerebral Venous Thrombosis: Associated Factors and Clinical Outcomes [J].
Bakradze, Ekaterina ;
Shu, Liqi ;
Henninger, Nils ;
Prabhakaran, Shyam ;
Siegler, James E. ;
De Marchis, Gian Marco ;
Giles, James A. ;
Dittrich, Tolga ;
Heldner, Mirjam R. ;
Antonenko, Kateryna ;
Kam, Wayneho ;
Liebeskind, David S. ;
Simpkins, Alexis N. ;
Nguyen, Thanh N. ;
Yaghi, Shadi ;
Liberman, Ava L. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (19)
[7]  
Barboza MA, 2018, Frontiers in Neurology, V9
[8]   Intracranial venous collaterals in cerebral venous thrombosis: clinical and imaging impact [J].
Barboza, Miguel A. ;
Mejias, Carolina ;
Colin-Luna, Jonathan ;
Quiroz-Compean, Alejandro ;
Arauz, Antonio .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (12) :1314-1318
[9]   Cerebral Venous Thrombosis: A Tunisian Monocenter Study on 160 Patients [J].
Ben Sassi, Samia ;
Touati, Nahla ;
Baccouche, Hela ;
Drissi, Cyrine ;
Romdhane, Neila Ben ;
Hentati, Faycal .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (08) :1005-1009
[10]  
Billoir P, 2023, Research and Practice in Thrombosis and Haemostasis, V7